*001828841
*00520250613174212.0
*007ta
*008020429s1997    xxu           000 u eng d
*00900711cam a22002057c 4500
*019  $bl
*035  $a(EXLNZ-47BIBSYS_NETWORK)990209769684702201
*035  $a(NO-LaBS)15196735(bibid)
*035  $a(NO-TrBIB)020976968
*035  $a020976968-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*24500$aEntry decisions in the generic pharmaceutical industry
*260  $aCambridge, Mass.$bNBER$c1997
*300  $a35 s.
*4901 $aNBER working paper series$v6190
*7001 $aMorton, Fiona M. Scott$_30208400
*7102 $aNational Bureau of Economic Research (Forente Stater)$_13074800
*830 0$aWorking paper series (National Bureau of Economic Research : trykt utg.)$x0898-2937$v6190$w999105437124702201$_13074900
*901  $a60
*999  $aoai:nb.bibsys.no:990209769684702202$b2021-11-14T20:52:43Z$z990209769684702202
^